Nations Financial Group’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$570K Sell
11,835
-2,784
-19% -$142K 0.03% 516
2026
Q2
$766K Buy
14,619
+219
+2% +$11.6K 0.04% 450
2026
Q1
$795K Buy
14,400
+1,458
+11% +$79K 0.04% 428
2025
Q4
$635K Buy
+12,942
New +$604K 0.03% 461

Other funds holding GSK

Nations Financial Group's GSK Position: Q3 2026 in Review

Nations Financial Group reduced its GSK (GSK) stake by 19% in Q3 2026, selling an estimated $142K and leaving 11,835 shares worth $570K. The position accounts for 0.03% of the portfolio, ranked #516.

Nations Financial Group first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $795K in Q1 2026. 558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Nations Financial Group held 11,835 shares of GSK worth $570K as of Q3 2026.
  • Nations Financial Group sold 2,784 GSK shares in Q3 2026, an estimated $142K.
  • GSK made up 0.03% of Nations Financial Group's portfolio in Q3 2026, its #516 holding.
  • Nations Financial Group first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Nations Financial Group's GSK position peaked at $795K in Q1 2026.
  • 558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Nations Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.